These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10930688)
1. Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. Dorrell L; O'Callaghan CA; Britton W; Hambleton S; McMichael A; Smith GL; Rowland-Jones S; Blanchard TJ Vaccine; 2000 Sep; 19(2-3):327-36. PubMed ID: 10930688 [TBL] [Abstract][Full Text] [Related]
2. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. Allen TM; Vogel TU; Fuller DH; Mothé BR; Steffen S; Boyson JE; Shipley T; Fuller J; Hanke T; Sette A; Altman JD; Moss B; McMichael AJ; Watkins DI J Immunol; 2000 May; 164(9):4968-78. PubMed ID: 10779808 [TBL] [Abstract][Full Text] [Related]
3. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. Berkhoff EG; Boon AC; Nieuwkoop NJ; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF J Virol; 2004 May; 78(10):5216-22. PubMed ID: 15113903 [TBL] [Abstract][Full Text] [Related]
4. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. McMichael AJ; Michie CA; Gotch FM; Smith GL; Moss B J Gen Virol; 1986 Apr; 67 ( Pt 4)():719-26. PubMed ID: 3485697 [TBL] [Abstract][Full Text] [Related]
5. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847 [TBL] [Abstract][Full Text] [Related]
6. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646 [TBL] [Abstract][Full Text] [Related]
7. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857 [TBL] [Abstract][Full Text] [Related]
8. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977 [TBL] [Abstract][Full Text] [Related]
9. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762 [TBL] [Abstract][Full Text] [Related]
10. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the specificity of cytotoxic T lymphocytes for the nucleoprotein of Pichinde virus using recombinant vaccinia viruses. Ozols DY; Harnish DG; Rawls WE; Rosenthal KL Arch Virol; 1990; 115(3-4):209-25. PubMed ID: 1701987 [TBL] [Abstract][Full Text] [Related]
13. Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence. Smith CL; Dunbar PR; Mirza F; Palmowski MJ; Shepherd D; Gilbert SC; Coulie P; Schneider J; Hoffman E; Hawkins R; Harris AL; Cerundolo V Int J Cancer; 2005 Jan; 113(2):259-66. PubMed ID: 15386406 [TBL] [Abstract][Full Text] [Related]
14. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses. Yu XG; Shang H; Addo MM; Eldridge RL; Phillips MN; Feeney ME; Strick D; Brander C; Goulder PJ; Rosenberg ES; Walker BD; Altfeld M; AIDS; 2002 Feb; 16(3):321-8. PubMed ID: 11834942 [TBL] [Abstract][Full Text] [Related]
15. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. Carreno BM; Turner RV; Biddison WE; Coligan JE J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522 [TBL] [Abstract][Full Text] [Related]
16. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses. Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364 [TBL] [Abstract][Full Text] [Related]
17. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo. Drexler I; Antunes E; Schmitz M; Wölfel T; Huber C; Erfle V; Rieber P; Theobald M; Sutter G Cancer Res; 1999 Oct; 59(19):4955-63. PubMed ID: 10519409 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen. Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334 [TBL] [Abstract][Full Text] [Related]
19. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
20. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]